The importance of
NADPH oxidase (Nox) in hypoxic responses in
hypoxia-sensing cells, including pulmonary artery smooth muscle cells (PASMCs), remains uncertain. In this study, using Western blot analysis we found that the major Nox subunits Nox1, Nox4, p22(
phox), p47(
phox), and p67(
phox) were equivalently expressed in mouse pulmonary and systemic (mesenteric) arteries. However, acute
hypoxia significantly increased Nox activity and translocation of p47(
phox)
protein to the plasma membrane in pulmonary, but not mesenteric, arteries. The Nox inhibitor
apocynin and p47(
phox) gene deletion attenuated the hypoxic increase in intracellular concentrations of
reactive oxygen species and Ca(2+) ([ROS](i) and [Ca(2+)](i)), as well as contractions in mouse PASMCs, and abolished the hypoxic activation of Nox in pulmonary arteries. The conventional/novel
protein kinase C (PKC) inhibitor
chelerythrine, specific PKCepsilon translocation
peptide inhibitor, and PKCepsilon gene deletion, but not the conventional PKC inhibitor
GO6976, prevented the hypoxic increase in Nox activity in pulmonary arteries and [ROS](i) in PASMCs. The PKC activator
phorbol 12-myristate 13-acetate could increase Nox activity in pulmonary and mesenteric arteries. Inhibition of mitochondrial ROS generation with
rotenone or
myxothiazol prevented hypoxic activation of Nox.
Glutathione peroxidase-1 (Gpx1) gene overexpression to enhance H(2)O(2) removal significantly inhibited the hypoxic activation of Nox, whereas Gpx1 gene deletion had the opposite effect. Exogenous H(2)O(2) increased Nox activity in pulmonary and mesenteric arteries. These findings suggest that acute
hypoxia may distinctively activate Nox to increase [ROS](i) through the mitochondrial ROS-PKCepsilon signaling axis, providing a positive feedback mechanism to contribute to the hypoxic increase in [ROS](i) and [Ca(2+)](i) as well as contraction in PASMCs.